Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 611-626 , September 2008

The immunocompromised pediatric patient and surgery

  • Barbara A. Castro, MD (Associate Professor of Anesthesiology and Pediatrics)

      Affiliations

    • Corresponding Author InformationTel.: +1 434 924 2283; Fax: +1 434 982 0019.

References 

  1. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. The Journal of Infectious Diseases. 2007 Jan 15;195(2):296–302
  2. Fleisher TA. Back to basics: primary immune deficiencies: windows into the immune system. Pediatrics in Review. 2006 Oct;27(10):363–372
  3. Fleisher TA, Bleesing JJ. Immune function. Pediatric Clinics of North America. 2000 Dec;47(6):1197–1209
  4. Patole S, Vijayakumar P, Jog S. Perinatal immunomodulation. The Journal of Maternal-Fetal & Neonatal Medicine. 2002 May;11(5):290–301
  5. Clapp DW. Developmental regulation of the immune system. Seminars in Perinatology. 2006 Apr;30(2):69–72
  6. Grigg J, Riedler J, Robertson CF, et al. Alveolar macrophage immaturity in infants and young children. The European Respiratory Journal. 1999 Nov;14(5):1198–1205
  7. Merry C, Puri P, Reen DJ. Defective neutrophil actin polymerisation and chemotaxis in stressed newborns. Journal of Pediatric Surgery. 1996 Apr;31(4):481–485
  8. Viemann D, Dubbel G, Schleifenbaum S, et al. Expression of toll-like receptors in neonatal sepsis. Pediatric Research. 2005 Oct;58(4):654–659
  9. Kenzel S, Henneke P. The innate immune system and its relevance to neonatal sepsis. Current Opinion in Infectious Diseases. 2006 Jun;19(3):264–270
  10. Strunk T, Richmond P, Simmer K, et al. Neonatal immune responses to coagulase-negative staphylococci. Current Opinion in Infectious Diseases. 2007 Aug;20(4):370–375
  11. Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatric Clinics of North America. 2000 Dec;47(6):1225–1252
  12. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn?. Clinical and Experimental Immunology. 2005 Jul;141(1):10–18
  13. Segal BH, Holland SM. Primary phagocytic disorders of childhood. Pediatric Clinics of North America. 2000 Dec;47(6):1311–1338
  14. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. The New England Journal of Medicine. 1991 Feb 21;324(8):509–516
  15. Frank MM. Complement deficiencies. Pediatric Clinics of North America. 2000 Dec;47(6):1339–1354
  16. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunological Reviews. 2005 Feb;203:38–47
  17. Elder ME. T-cell immunodeficiencies. Pediatric Clinics of North America. 2000 Dec;47(6):1253–1274
  18. Chinen J, Shearer WT. 6. Secondary immunodeficiencies, including HIV infection. The Journal of Allergy and Clinical Immunology. 2008 Feb;121(2 Suppl):S388–S392quiz S417
  19. Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. The British Journal of Nutrition. 2007 Oct;98(Suppl 1):S29–S35
  20. Bowley DM, Rogers TN, Meyers T, Pitcher G. Surgeons are failing to recognize children with HIV infection. Journal of Pediatric Surgery. 2007 Feb;42(2):431–434
  21. Leelanukrom R, Pancharoen C. Anesthesia in HIV-infected children. Paediatric Anaesthesia. 2007 Jun;17(6):509–519
  22. Evron S, Glezerman M, Harow E, et al. Human immunodeficiency virus: anesthetic and obstetric considerations. Anesthesia and Analgesia. 2004 Feb;98(2):503–511
  23. Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatric Clinics of North America. 2003 Dec;50(6):1283–1300
  24. Marchant WA, Walker I. Anaesthetic management of the child with sickle cell disease. Paediatric Anaesthesia. 2003 Jul;13(6):473–489
  25. Donadi EA, Falcao RP. Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy. Journal of Clinical Pathology. 1987 Jun;40(6):670–672
  26. William BM, Corazza GR. Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology. 2007 Feb;12(1):1–13
  27. Pearson HA, Cornelius EA, Schwartz AD, et al. Transfusion-reversible functional asplenia in young children with sickle-cell anemia. The New England Journal of Medicine. 1970 Aug 13;283(7):334–337
  28. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. The Journal of Pediatrics. 2001 Dec;139(6):790–796
  29. William BM, Thawani N, Sae-Tia S, Corazza GR. Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management. Hematology. 2007 Apr;12(2):89–98
  30. Hubeau C, Lorenzato M, Couetil JP, et al. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clinical and Experimental Immunology. 2001 Apr;124(1):69–76
  31. Elborn JS, Prescott RJ, Stack BH, et al. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic pseudomonas infection of the lungs. Thorax. 2000 May;55(5):355–358
  32. Casaulta C, Schoni MH, Weichel M, et al. IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis. Pediatric Research. 2003 Feb;53(2):313–319
  33. Rao S, Grigg J. New insights into pulmonary inflammation in cystic fibrosis. Archives of Disease in Childhood. 2006 Sep;91(9):786–788
  34. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatric Pulmonology. 1997 Aug;24(2):137–142[discussion 59–61]
  35. Alexis NE, Muhlebach MS, Peden DB, Noah TL. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. Journal of Cystic Fibrosis. 2006 Jan;5(1):17–25
  36. Dakin CJ, Numa AH, Wang H, et al. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 2002 Apr;165(7):904–910
  37. Armstrong DS, Hook SM, Jamsen KM, et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatric Pulmonology. 2005 Dec;40(6):500–510
  38. Cigana C, Nicolis E, Pasetto M, et al. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochemical and Biophysical Research Communications. 2006 Dec 1;350(4):977–982
  39. Shinkai M, Rubin BK. Macrolides and airway inflammation in children. Paediatric Respiratory Reviews. 2005 Sep;6(3):227–235
  40. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disese Control and Prevention, u.s. Pediatrics. 2002 Nov;110(5):e51
  41. Voit SB, Todd JK, Nelson B, Nyquist AC. Electronic surveillance system for monitoring surgical antimicrobial prophylaxis. Pediatrics. 2005 Dec;116(6):1317–1322
  42. Schwartz SA. Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatric Clinics of North America. 2000 Dec;47(6):1355–1369
  43. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database of Systematic Reviews. 2004;(1):CD000361
  44. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database of Systematic Reviews. 2004;(1):CD001239
  45. Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database of Systematic Reviews. 2003;(3):CD003066
  46. Stevenson GW, Hall SC, Rudnick S, et al. The effect of anesthetic agents on the human immune response. Anesthesiology. 1990 Mar;72(3):542–552
  47. Loop T, Dovi-Akue D, Frick M, et al. Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology. 2005 Jun;102(6):1147–1157
  48. Yossuck P, Nightengale BJ, Fortney JE, Gibson LF. Effect of morphine sulfate on neonatal neutrophil chemotaxis. The Clinical Journal of Pain. 2008 Jan;24(1):76–82
  49. Budd K. Pain management: is opioid immunosuppression a clinical problem?. Biomedicine & Pharmacotherapy. 2006 Aug;60(7):310–317
  50. Wei G, Moss J, Yuan CS. Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?. Biochemical Pharmacology. 2003 Jun 1;65(11):1761–1766
  51. Chen RM, Wu CH, Chang HC, et al. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology. 2003 May;98(5):1178–1185
  52. Melamed R, Bar-Yosef S, Shakhar G, et al. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and Analgesia. 2003 Nov;97(5):1331–1339
  53. Schneemilch CE, Ittenson A, Ansorge S, et al. Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery. Journal of Clinical Anesthesia. 2005 Nov;17(7):517–527

PII: S1521-6896(08)00050-5

doi: 10.1016/j.bpa.2008.05.006

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 611-626 , September 2008

Article Tools